Status:
COMPLETED
A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator
Lead Sponsor:
Metabolic Solutions Development Company
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if MSDC-0160 is effective in the treatment of Type 2 diabetes.
Eligibility Criteria
Inclusion
- Diagnosis of Type 2 Diabetes naive or on metformin
- Male and female (postmenopausal or surgically sterilized), 18 to 70 years of age.
Exclusion
- Use of diabetes medications other than metformin.
- History of heart failure or previous myocardial infarction.
- Blood pressure great than 160/100 mmHg.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00760578
Start Date
September 1 2008
End Date
February 1 2009
Last Update
May 3 2013
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles, California, United States
2
Miami Gardens, Florida, United States
3
West Palm Beach, Florida, United States
4
Kalamazoo, Michigan, United States